Clinical trial
The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
NCT02622386 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
- Lead sponsor
- University of Michigan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 11, 2016
- Completion date
- April 6, 2020
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.